🔎 Trials Near Me

Home › Colorectal Cancer › California › Mountain View

Pag-aaral pangklinika para sa Colorectal Cancer sa Mountain View, CA

Isang pag-aaral para sa Colorectal Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Mountain View. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Nagre-recruitPhase 3
  • Palo Alto Medical Foundation - Palo Alto Center, Palo Alto · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07222800

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Nagre-recruitObservasyonal na pag-aaral
  • Stanford University, Palo Alto · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04981119

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Nagre-recruitPhase 1
  • Stanford University Medical Center, Stanford · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Nagre-recruitPhase 1
  • Stanford University Medical Center, Stanford · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213791

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2
  • Stanford Cancer Institute, Stanford · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients

Nagre-recruit
  • Stanford University, Palo Alto · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07403981

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Nagre-recruitPhase 3
  • Clinical Study Site, Stanford · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07228832

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2
  • Stanford Cancer Institute, Stanford University, Palo Alto · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05919264

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Nagre-recruitPhase 1
  • Stanford University Medical Center, Palo Alto · 5 mi ang layo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT06562192

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Nagre-recruitPhase 1
  • Stanford University, Palo Alto · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT06179160

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Nagre-recruitPhase 1/2
  • Stanford University, Stanford · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT06051695

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

Nagre-recruitPhase 1/2
  • Stanford Hospital & Clinics, Stanford · 5 mi ang layo
Edad 15 pataas · Lahat ng kasarian · Na-update Ago 12, 2025 · NCT06298916

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Nagre-recruitPhase 1
  • Stanford University, Stanford · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 8, 2024 · NCT04282044

Pag-aaral para sa Colorectal Cancer sa ibang lungsod

Iba pang pag-aaral sa Mountain View

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.